Canada markets closed

Medtronic plc (MDT)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
102.98-1.37 (-1.31%)
At close: 4:00PM EDT

102.98 0.00 (0.00%)
After hours: 4:46PM EDT

Full screen
Trade prices are not sourced from all markets
Previous Close104.35
Open104.34
Bid102.42 x 900
Ask103.80 x 900
Day's Range102.92 - 104.78
52 Week Range72.13 - 122.15
Volume4,904,940
Avg. Volume4,812,417
Market Cap138.428B
Beta (5Y Monthly)0.69
PE Ratio (TTM)31.59
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield2.32 (2.22%)
Ex-Dividend DateSep. 24, 2020
1y Target EstN/A
All
News
Press Releases
  • Medtronic Canada Recognized as One of the Best Workplaces™ in Healthcare for the Second Consecutive Year
    CNW Group

    Medtronic Canada Recognized as One of the Best Workplaces™ in Healthcare for the Second Consecutive Year

    BRAMPTON, ON, Sept. 15, 2020 /CNW/ - Medtronic Canada ULC, a subsidiary of Medtronic plc (NYSE: MDT) — one of the world's largest medical technology, services, and solutions companies — announced today that it has been recognized as one of the Best Workplaces in Healthcare for the second consecutive year.

  • Medtronic CEO Geoff Martha to Speak at Morgan Stanley Global Healthcare Conference
    CNW Group

    Medtronic CEO Geoff Martha to Speak at Morgan Stanley Global Healthcare Conference

    DUBLIN, Sept. 11, 2020 /CNW/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the Morgan Stanley 18th Annual Global Healthcare Conference on Monday, September 14, 2020.

  • Medtronic Study Finds Opioid-Induced Respiratory Depression in the Hospital More Common and Costly
    CNW Group

    Medtronic Study Finds Opioid-Induced Respiratory Depression in the Hospital More Common and Costly

    * PRODIGY Study Provides First Validated Risk Prediction Tool to Guide Continuous Monitoring for Opioid-Induced Respiratory Depression (OIRD) * OIRD Occurred in 46% of Patients Studied * Patients with Respiratory Depression Are 37% More Likely to Experience an Adverse Event and Require Longer Hospital StaysDUBLIN, Sept. Importantly, conclusions from the study data enabled the development of the PRODIGY Risk Score, an easy-to-use risk prediction tool to identify patients at high risk of respiratory depression who would benefit from continuous monitoring with capnography and pulse oximetry.